Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: TREXIMET — Supplemental Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for TREXIMET (sumatriptan succinate and naproxen sodium) from Currax Pharmaceuticals LLC. This action authorizes the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

SUPPL AP for TREXIMET (SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM)